Letter to the Editor
Primary cytomegalovirus infection in a patient with relapsing-remitting multiple sclerosis under treatment with alemtuzumab
Primoinfección por citomegalovirus en un paciente con esclerosis múltiple recurrente-remitente tratado con alemtuzumab
Read
2101
Timeswas read the article
416
Total PDF
1685
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 December | 25 | 3 | 28 |
| 2024 November | 29 | 4 | 33 |
| 2024 October | 33 | 0 | 33 |
| 2024 September | 77 | 1 | 78 |
| 2024 August | 39 | 9 | 48 |
| 2024 July | 30 | 1 | 31 |
| 2024 June | 58 | 8 | 66 |
| 2024 May | 55 | 6 | 61 |
| 2024 April | 36 | 3 | 39 |
| 2024 March | 43 | 7 | 50 |
| 2024 February | 54 | 3 | 57 |
| 2024 January | 56 | 13 | 69 |
| 2023 December | 51 | 6 | 57 |
| 2023 November | 61 | 8 | 69 |
| 2023 October | 49 | 5 | 54 |
| 2023 September | 23 | 0 | 23 |
| 2023 August | 20 | 4 | 24 |
| 2023 July | 17 | 2 | 19 |
| 2023 June | 21 | 5 | 26 |
| 2023 May | 14 | 5 | 19 |
| 2023 April | 29 | 2 | 31 |
| 2023 March | 13 | 4 | 17 |
| 2023 February | 17 | 4 | 21 |
| 2023 January | 22 | 4 | 26 |
| 2022 December | 32 | 15 | 47 |
| 2022 November | 40 | 5 | 45 |
| 2022 October | 18 | 9 | 27 |
| 2022 September | 22 | 14 | 36 |
| 2022 August | 48 | 10 | 58 |
| 2022 July | 27 | 6 | 33 |
| 2022 June | 13 | 4 | 17 |
| 2022 May | 22 | 14 | 36 |
| 2022 April | 50 | 16 | 66 |
| 2022 March | 48 | 11 | 59 |
| 2022 February | 35 | 3 | 38 |
| 2022 January | 31 | 7 | 38 |
| 2021 December | 44 | 9 | 53 |
| 2021 November | 23 | 9 | 32 |
| 2021 October | 29 | 11 | 40 |
| 2021 September | 29 | 10 | 39 |
| 2021 August | 36 | 6 | 42 |
| 2021 July | 24 | 7 | 31 |
| 2021 June | 23 | 11 | 34 |
| 2021 May | 21 | 8 | 29 |
| 2021 April | 60 | 28 | 88 |
| 2021 March | 24 | 9 | 33 |
| 2021 February | 26 | 9 | 35 |
| 2021 January | 20 | 12 | 32 |
| 2020 December | 15 | 9 | 24 |
| 2020 November | 11 | 7 | 18 |
| 2020 October | 8 | 9 | 17 |
| 2020 September | 10 | 10 | 20 |
| 2020 August | 19 | 15 | 34 |
| 2020 July | 5 | 16 | 21 |
Show all
